Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel

Melanie D. Swift; Laura E. Breeher; Aaron J. Tande; Christopher P. Tommaso; Caitlin M. Hainy; Haitao Chu; M. Hassan Murad; Elie F. Berbari; Abinash Virk

doi:10.1093/cid/ciab361

Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel

Melanie D. Swift
, Laura E. Breeher
, Aaron J. Tande
, Christopher P. Tommaso
, Caitlin M. Hainy
, Haitao Chu
, M. Hassan Murad
, Elie F. Berbari
, Abinash Virk

Biostatistics

Research output: Contribution to journal › Article › peer-review

72 Scopus citations

Abstract

In a large cohort of United States healthcare personnel without prior coronavirus disease 2019 (COVID-19) infection, 94 382 doses of messenger RNA (mRNA) COVID-19 vaccine were administered to 49 220 individuals. The adjusted vaccine effectiveness following 2 doses of each of the 2 available brands of mRNA vaccine exceeded 96%.

Original language	English (US)
Pages (from-to)	E1376-E1379
Journal	Clinical Infectious Diseases
Volume	73
Issue number	6
DOIs	https://doi.org/10.1093/cid/ciab361
State	Published - Sep 15 2021

Bibliographical note

Publisher Copyright:
© The Author(s) 2021.

Keywords

COVID-19
SARS-CoV-2
healthcare personnel
mRNA
vaccine effectiveness

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1093/cid/ciab361

Find It

Find It at U of M Libraries

Cite this

Swift, M. D., Breeher, L. E., Tande, A. J., Tommaso, C. P., Hainy, C. M., Chu, H., Murad, M. H., Berbari, E. F., & Virk, A. (2021). Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel. Clinical Infectious Diseases, 73(6), E1376-E1379. https://doi.org/10.1093/cid/ciab361

Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel. / Swift, Melanie D.; Breeher, Laura E.; Tande, Aaron J. et al.
In: Clinical Infectious Diseases, Vol. 73, No. 6, 15.09.2021, p. E1376-E1379.

Research output: Contribution to journal › Article › peer-review

Swift, MD, Breeher, LE, Tande, AJ, Tommaso, CP, Hainy, CM, Chu, H, Murad, MH, Berbari, EF & Virk, A 2021, 'Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel', Clinical Infectious Diseases, vol. 73, no. 6, pp. E1376-E1379. https://doi.org/10.1093/cid/ciab361

@article{c69082c0bcaa4ea1903494e6586c5935,

title = "Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel",

abstract = "In a large cohort of United States healthcare personnel without prior coronavirus disease 2019 (COVID-19) infection, 94 382 doses of messenger RNA (mRNA) COVID-19 vaccine were administered to 49 220 individuals. The adjusted vaccine effectiveness following 2 doses of each of the 2 available brands of mRNA vaccine exceeded 96\%.",

keywords = "COVID-19, SARS-CoV-2, healthcare personnel, mRNA, vaccine effectiveness",

author = "Swift, \{Melanie D.\} and Breeher, \{Laura E.\} and Tande, \{Aaron J.\} and Tommaso, \{Christopher P.\} and Hainy, \{Caitlin M.\} and Haitao Chu and Murad, \{M. Hassan\} and Berbari, \{Elie F.\} and Abinash Virk",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2021.",

year = "2021",

month = sep,

day = "15",

doi = "10.1093/cid/ciab361",

language = "English (US)",

volume = "73",

pages = "E1376--E1379",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel

AU - Swift, Melanie D.

AU - Breeher, Laura E.

AU - Tande, Aaron J.

AU - Tommaso, Christopher P.

AU - Hainy, Caitlin M.

AU - Chu, Haitao

AU - Murad, M. Hassan

AU - Berbari, Elie F.

AU - Virk, Abinash

PY - 2021/9/15

Y1 - 2021/9/15

N2 - In a large cohort of United States healthcare personnel without prior coronavirus disease 2019 (COVID-19) infection, 94 382 doses of messenger RNA (mRNA) COVID-19 vaccine were administered to 49 220 individuals. The adjusted vaccine effectiveness following 2 doses of each of the 2 available brands of mRNA vaccine exceeded 96%.

AB - In a large cohort of United States healthcare personnel without prior coronavirus disease 2019 (COVID-19) infection, 94 382 doses of messenger RNA (mRNA) COVID-19 vaccine were administered to 49 220 individuals. The adjusted vaccine effectiveness following 2 doses of each of the 2 available brands of mRNA vaccine exceeded 96%.

KW - COVID-19

KW - SARS-CoV-2

KW - healthcare personnel

KW - mRNA

KW - vaccine effectiveness

UR - https://www.scopus.com/pages/publications/85114793941

UR - https://www.scopus.com/pages/publications/85114793941#tab=citedBy

U2 - 10.1093/cid/ciab361

DO - 10.1093/cid/ciab361

M3 - Article

C2 - 33900384

AN - SCOPUS:85114793941

SN - 1058-4838

VL - 73

SP - E1376-E1379

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 6

ER -

Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel

Abstract

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this